Many years ago, on a family visit to Ahmedabad, we stayed with friends who were strict Jains. Being a bratty teenager, I wanted a non-vegetarian meal and their son offered, with alacrity, to ...
The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.
In this case, if resistance, 61.63, is being tested a short signal would exist. Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the ...